Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Amgen

Amgen 'Laser-Focused' On Its Weight-Loss Shot As New Rival Pfizer Follows, Says CFO

Amgen is focusing deeply on its efforts to treat obesity, the CFO said Wednesday. Amgen stock rose early Thursday.

Investors Business Daily

3 Top Healthcare Stocks to Buy for Growth and Dividends

3 Top Healthcare Stocks to Buy for Growth and Dividends

Investors seeking growth and dividend income in the healthcare sector may want to consider Eli Lilly, Gilead Sciences, and Amgen, which have delivered impressive returns and boast strong pipelines and strategic moves.

Why Amgen's Obesity Drug — And $5 Billion Opportunity — Led To A Downgrade

Why Amgen's Obesity Drug — And $5 Billion Opportunity — Led To A Downgrade

Amgen stock dipped Monday after an analyst downgraded shares, saying the opportunity for its weight-loss drug is already baked into the stock.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Dow Jones Rises After Inflation Data; Tesla Plunges On Robotaxi Event

Stock Market Today: The Dow Jones rose Friday after key inflation data. Tesla stock plunged after its Robotaxi event.

Investors Business Daily

How To Invest: Biotechs Can Make Huge Gains But Have Unique Risks

In some cases, biotechs go public without having even a single product on the market.

Investors Business Daily

Dow Jones Falls On Hot Inflation Data; Tesla Slides Ahead Of Robotaxi Event

Stock Market Today: The Dow Jones dropped Thursday on a hot inflation report. Tesla skidded before its Robotaxi event.

Investors Business Daily

Dow Jones Rallies On Strong Jobs Report; Nvidia Nears Buy Point

Stock Market Today: The Dow Jones rallied Friday on a strong September jobs report. Nvidia stock is nearing a new buy point.

Investors Business Daily

inkl

Read news from The Economist, FT, and more,
with one subscription

Eli Lilly Leads S&P Health Care Stocks With 1,241% Gain. But The Others Aren't Slackers.

Eli Lilly Leads S&P Health Care Stocks With 1,241% Gain. But The Others Aren't Slackers.

Eli Lilly has gained markedly over the past decade. But it's not the only S&P 500 health care stock to notch a bullish gain.

Investors Business Daily

Stock Market Rally Hits Fresh Highs, Fueled By Micron Earnings, China Stimulus: Weekly Review

The stock market rally extended its advance, with the S&P 500 hitting record highs, fueled by Micron and Chinese stimulus.

Investors Business Daily

Argenx Stock Surges As Amgen Struggles To Take On 'The King' In Autoimmune Diseases

Argenx Stock Surges As Amgen Struggles To Take On 'The King' In Autoimmune Diseases

Argenx stock surged Wednesday after Amgen presented "underwhelming" results for a potential competitor to Vyvgart in an autoimmune disease.

Investors Business Daily

Regeneron Dives As Amgen Tees Up Its Rival To Moneymaking Machine Eylea

Regeneron Dives As Amgen Tees Up Its Rival To Moneymaking Machine Eylea

Regeneron stock toppled Monday after a judge unexpectedly rejected a request that would have prevented Amgen from launching an Eylea copycat.

Investors Business Daily

How This Amgen Rival Is Taking On The Company's $28 Billion Acquisition

How This Amgen Rival Is Taking On The Company's $28 Billion Acquisition

Viridian Therapeutics stock jumped Tuesday after unveiling promising results for its Amgen-rivaling eye disease treatment.

Investors Business Daily

Is Amgen Stock Outperforming the Nasdaq?

Is Amgen Stock Outperforming the Nasdaq?

Amgen has surpassed the Nasdaq recently, and analysts are cautiously optimistic about its future potential.

The 10 Pharma Stocks To Watch — Including Viking, Roche And Amgen — Amid The Fast-Growing Obesity Drug Race

The 10 Pharma Stocks To Watch — Including Viking, Roche And Amgen — Amid The Fast-Growing Obesity Drug Race

The weight-loss drugs market could be worth up to $144 billion within six years. And a bevy of pharma stocks could get a lift.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

AMGN Bullish Diagonal Trade Targets a Price of $350 by October 18th

A bullish diagonal spread is an advanced option trade and generally not suitable for beginners, but it can have its place within an option portfolio.

Are Wall Street Analysts Bullish on Amgen Stock?

Amgen has outperformed the broader market over the past year, yet Wall Street analysts remain cautiously optimistic about the stock’s prospects.

Investors Business Daily

Dow Jones Rallies 300 Points; Nvidia Partner Super Micro Plunges On Earnings (Live Coverage)

Stock Market Today: The Dow Jones rallied 300 points Wednesday, as Nvidia partner Super Micro plunged on weak earnings results.

Investors Business Daily

Dow Jones Futures Fuel New Market Rally On Bank Of Japan; Nvidia Partner Super Micro Dives

Futures added to a new market rally attempt thanks to Bank of Japan comments. Nvidia partner Super Micro was a big earnings loser.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Why Biotech Giant Amgen Stands A Chance Of Taking On Novo, Lilly In Obesity

Amgen's obesity treatment, MariTide, continues to dominate the conversation, an analyst said Wednesday as Amgen stock slipped.

Investors Business Daily

Dow Jones Bounces After Stock Market Rout; Palantir, Uber Surge On Earnings (Live Coverage)

Stock Market Today: The Dow Jones bounced Tuesday after the stock market rout. Palantir stock and Uber surged on earnings.

Investors Business Daily

Dow Jones Futures Bounce: 'Fear Index' Soars As Apple, Nvidia, Tesla Dive; AI Stock Palantir Surges On Earnings

Dow Jones Futures Rebound: The VIX, also known as the fear index, soared as Apple, Nvidia and Tesla plunged. Palantir surged on earnings late.

Investors Business Daily

Dow Jones Plunges In Broad Sell-Off; Nvidia Plummets On AI Chip Flaw As Warren Buffett Unloads Apple Stock (Live Coverage)

The Dow lost 900 points and fell below a psychological level on Monday. Nvidia announced a chip design flaw and dragged Magnificent Seven stocks lower.

After the Fed tipped markets over, now what?

Traders slam stocks to open August, one of the market's weakest months of the year.

What You Need to Know Ahead of Amgen's Earnings Release

Amgen is expected to release its fiscal second-quarter earnings next month, and analysts project a single-digit profit dip.

Investors Business Daily

Eli Lilly, Novo Nordisk — And Their Rivals — Skid On Roche's Weight-Loss Drug Results

Eli Lilly and Novo Nordisk fell Wednesday after Roche released positive early-stage trial data on its oral weight-loss drug.

1 2 3 4 5

People

King Charles III

Mark Zuckerberg

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Autoimmune Disease

Places

231,327 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play